kff 2025 employer health benefits survey glp-1 coverage This chart, from the annual Survey, is the most important visual in all of health policy. Premiums in employer plans were up big in 2025. They were up Employers Grapple With GLP-1 Coverage

M.Vzquez-MezaH

More commonly, a standardized extract containing the most active constituents can be made from the leaves and then taken as a tablet, in liquid form, or given intravenously (Kleijnen and Knipschild, 1992)

They point to effects beyond appetite suppression, from reduced inflammation to possible direct signalling on tumour cells. F&B takeaway: It almost goes without saying that GLP-1s for cancer prevention or treatment would dramatically accelerate their adoption, both in private use and in public health systems, shifting them firmly into the health space

GLP-1 medications are often placed on higher formulary tiers, resulting in higher cost-sharing

"Recent data published by Kaiser in June or July of this year showed that most people aren't staying on for even a year, whether due to insurance constraints or self selection

OR: 0.86, p = 0.02) and reduced 90-day postoperative costs ($15,291.66 vs